Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mauro

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
American Journal of Hematology|November 4, 2017
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed casesMassimo Gentile, Tait D Shanafelt, Francesca R Mauro, et al.
Leukemia|September 20, 2017
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profileI Del Giudice, G M Rigolin, S Raponi, et al.
European Journal of Haematology|March 11, 2015
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Stefano Molica, et al.
British Journal of Haematology|March 12, 2022
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapyMaria-Teresa Voso, Tatjana Pandzic, Giulia Falconi, et al.
Cancers|June 10, 2023
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter StudyFrancesca R Mauro, Diana Giannarelli, Clementina M Galluzzo, et al.
Leukemia|November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II TrialA Cortelezzi, M Sciumè, A M Liberati, et al.
British Journal of Haematology|August 1, 2019
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experienceIdanna Innocenti, Francesca Morelli, Francesco Autore, et al.
Blood|November 23, 2000
Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemiaS Bevan, D Catovsky, E Matutes, et al.
British Journal of Haematology|May 23, 2018
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive diseaseSara Raponi, Ilaria Del Giudice, Caterina Ilari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2018
Genetic landscape of ultra-stable chronic lymphocytic leukemia patientsS Raponi, I Del Giudice, M Marinelli, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
American Journal of Hematology|November 4, 2017
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed casesMassimo Gentile, Tait D Shanafelt, Francesca R Mauro, et al.
Leukemia|September 20, 2017
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profileI Del Giudice, G M Rigolin, S Raponi, et al.
European Journal of Haematology|March 11, 2015
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Stefano Molica, et al.
British Journal of Haematology|March 12, 2022
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapyMaria-Teresa Voso, Tatjana Pandzic, Giulia Falconi, et al.
Cancers|June 10, 2023
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter StudyFrancesca R Mauro, Diana Giannarelli, Clementina M Galluzzo, et al.
Leukemia|November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II TrialA Cortelezzi, M Sciumè, A M Liberati, et al.
British Journal of Haematology|August 1, 2019
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experienceIdanna Innocenti, Francesca Morelli, Francesco Autore, et al.
Blood|November 23, 2000
Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemiaS Bevan, D Catovsky, E Matutes, et al.
British Journal of Haematology|May 23, 2018
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive diseaseSara Raponi, Ilaria Del Giudice, Caterina Ilari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2018
Genetic landscape of ultra-stable chronic lymphocytic leukemia patientsS Raponi, I Del Giudice, M Marinelli, et al.
Pageof 14